Trial Profile
The Effect of Sitagliptin Treatment on Glucose Metabolism and Endothelial Function in Renal Transplant Recipients - JANUVIA-08.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Diabetes mellitus; Glucose intolerance
- Focus Pharmacodynamics
- 11 Sep 2013 Results presented at the 16th Congress of the European Society for Organ Transplantation.
- 01 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jan 2012 Additional lead trial centre identified as reported by ClinicalTrials.gov.